Federal district court cases that are filed pursuant to the Hatch-Waxman Act and Post Grant Proceedings at the PTAB involving Orange Book-listed patents
This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same information for proceedings before the Patent Trial and Appeal Board concerning Orange Book-listed patents.
| Case Name | Date Filed | Judge | Drug | Patent No(s). |
| American Regent, Inc. v. Hikma Pharms. USA Inc., 25-2224 (D.N.J.) | Apr. 1, 2025 | Hon. Brian R. Martinotti | Tralement® (trace elements zinc sulfate / cupric sulfate / manganese sulfate / selenious acid injection) |
11,786,548 11,975,022 11,998,565 12,150,956 12,150,957 |
| Merck Sharp & Dohme B.V. v. Xiromed Pharma España, S.L., 25-2254 (D.N.J.) | Apr. 2, 2025 | Hon. Claire C. Cecchi | Nexplanon® (etonogestrel implant) |
8,722,037 9,757,552 |
| Urovant Sciences GmbH v. Annora Pharma Private Ltd., 25-0419 (D. Del.) | Apr. 3, 2025 | Hon. Gregory B. Williams | Gemtesa® (vibegron tablets) |
12,102,638 |
| Urovant Sciences GmbH v. MSN Labs. Private Ltd., 25-0420 (D. Del.) | Apr. 3, 2025 | Hon. Gregory B. Williams | Gemtesa® (vibegron tablets) |
12,102,638 |
| AbbVie Inc. v. Aurobindo Pharma USA, Inc., 25-0422 (D. Del.) | Apr. 4, 2025 | Hon. Maryellen Noreika | Rinvoq® (upadacitinib extended-release tablets) |
RE47,221 |
| Melinta Therapeutics, LLC v. Gland Pharma Ltd., 25-3676 (N.D. Ill.) | Apr. 4, 2025 | Hon. Jeremy C. Daniel | Minocin® (minocycline injection) |
9,278,105 9,084,802 11,944,634 12,161,656 |
| Salix Pharms., Inc. v. SABA Ilac Sanayi ve Ticaret A.S., 25-2307 (D.N.J.) | Apr. 4, 2025 | Hon. John F. Murphy | Xifaxan® (rifaximin tablets) |
11,564,912 11,779,571 8,193,196 7,928,115 |
| Exelixis, Inc. v. Sun Pharm. Indus. Ltd., 25-0423 (D. Del.) | Apr. 4, 2025 | Hon. Richard G. Andrews | Cabometyx® (cabozantinib tablets) |
12,128,039 |
| Pfizer Inc. v. Annora Pharma Private Ltd., 25-0424 (D. Del.) | Apr. 4, 2025 | Hon. Colm F. Connolly | Xeljanz® (tofacitinib tablets) |
RE41,783 |
| Hetero Labs Ltd. v. AbbVie Inc., 25-0431 (D. Del.) | Apr. 7, 2025 | Hon. Jennifer L. Hall | Orilissa® (elagolix sodium tablets) |
12,102,637 |
| Aurinia Pharms. Inc. v. Hikma Pharms. USA Inc., 25-2580 (D.N.J.) | Apr. 10, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Ascendis Pharma A/S v. BioMarin Pharm. Inc., 25-3302 (N.D. Cal.) | Apr. 11, 2025 | Hon. Joseph C. Spero | Voxzogo® (vosoritide injection) |
RE48,267 |
| Merck Sharp & Dohme LLC v. Aurobindo Pharma Ltd., 25-0449 (D. Del.) | Apr. 11, 2025 | Hon. Richard G. Andrews | Janumet XR® (metformin HCl / sitagliptin phosphate extended-release tablets) |
7,326,708 |
| Aurinia Pharms. Inc. v. Lotus Pharm. Co., Ltd., 25-2613 (D.N.J.) | Apr. 11, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| American Regent, Inc. v. Amneal Pharms. of NY, LLC, 25-2642 (D.N.J.) | Apr. 11, 2025 | Hon. Brian R. Martinotti | Tralement® (trace elements zinc sulfate / cupric sulfate / manganese sulfate / selenious acid injection) |
11,786,548 11,975,022 11,998,565 12,150,956 12,150,957 |
| Vertex Pharms. Inc. v. Lupin Ltd., 25-0450 (D. Del.) | Apr. 11, 2025 | Hon Richard G. Andrews | Kalydeco® (ivacaftor granules) |
8,883,206 10,272,046 10,646,481 11,147,770 11,564,916 11,752,106 12,214,083 |
| Exelixis, Inc. v. Biocon Pharma Ltd., 25-0452 (D. Del.) | Apr. 11, 2025 | Hon Richard G. Andrews | Cabometyx® (cabozantinib(S)-malate tablets) |
8,877,776 11,091,439 11,091,440 11,098,015 12,128,039 |
| Veloxis Pharms., Inc. v. Glenmark Pharms. Inc., 25-0458 (D. Del.) | Apr. 14, 2025 | Hon. Maryellen Noreika | Envarsus XR® (tacrolimus extended-release tablets) |
8,685,998 9,549,918 10,166,190 10,864,199 11,110,081 11,123,331 11,419,823 12,083,103 |
| Jazz Pharms., Inc. v. Almaject, Inc., 25-2785 (D.N.J.) | Apr. 16, 2025 | Hon. Stanley R. Chesler | Defitelio® (defibrotide sodium injection) |
11,085,043 11,236,328 11,746,348 |
| Aurinia Pharms. Inc. v. Galenicum Health S.L.U., 25-2807 (D.N.J.) | Apr. 17, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Aragon Pharms., Inc. v. Lupin Ltd., 25-2860 (D.N.J.) | Apr. 18, 2025 | Hon. Stanley R. Chesler | Erleada® (apalutamide tablets) |
11,963,952 |
| Fresenius Kabi USA, LLC v. Endo Operations Ltd., 25-2861 (D.N.J.) | Apr. 18, 2025 | Hon. Susan D. Wigenton | levothyroxine sodium injection | 9,782,376 10,398,669 11,135,190 |
| Exelixis, Inc. v. Azurity Pharms., Inc., 25-0478 (D. Del.) | Apr. 18, 2025 | Hon. Richard G. Andrews | Cabometyx® (cabozantinib (S)-malate tablets) |
8,877,776 11,091,439 11,091,440 11,098,015 11,298,349 12,128,039 |
| Adverio Pharma GmbH v. Changzhou Pharm. Factory, 25-0479 (D. Del.) | Apr. 18, 2025 | Hon. Gregory B. Williams | Verquvo® (vericiguat tablets) |
8,420,656 8,921,377 9,604,948 9,993,476 10,736,896 11,439,642 |
| Aurinia Pharms. Inc. v. Zydus Pharms. (USA) Inc., 25-2893 (D.N.J.) | Apr. 21, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Tris Pharma, Inc. v. Granules Pharms., Inc., 25-0498 (D. Del.) | Apr. 24, 2025 | Hon. Jennifer L. Hall | Dyanavel® XR (amphetamine extended-release tablets) |
11,590,081 |
| Onyx Therapeutics, Inc. v. Somerset Therapeutics, LLC, 25-0500 (D. Del.) | Apr. 24, 2025 | Hon. Gregory B. Williams | Kyprolis® (carfilzomib injection) |
7,737,112 |
| Pharmacosmos A/S v. Teva Pharms., Inc., 25-3218 (D.N.J.) | Apr. 24, 2025 | Hon. Julien Xavier Neals | Cosela® (trilaciclib injection) |
11,529,352 12,168,666 |
| Aurinia Pharms. Inc. v. Teva Pharms., Inc., 25-3267 (D.N.J.) | Apr. 25, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Mitsubishi Tanabe Pharma Corp. v. Shanghai Auzone Biological Technology Co., Ltd., 25-3326 (D.N.J.) | Apr. 25, 2025 | Hon. Claire C. Cecchi | Radicava ORS® (edaravone oral suspension) |
10,987,341 11,241,416 11,478,450 11,826,352 11,957,660 |
| Vifor (Int’l) AG v. MSN Labs. Private Ltd., 25-3286 (D.N.J.) | Apr. 25, 2025 | Hon. Georgette Castner | Injectafer® (ferric carboxymaltose injection) |
7,612,109 7,754,702 8,895,612 11,364,260 11,433,091 11,478,502 |
| Impax Labs., LLC v. Qilu Pharm. (Hainan) Co., Ltd., 25-3292 (D.N.J.) | Apr. 25, 2025 | Hon. Brian R. Martinotti | Rytary® (carbidopa / levodopa extended-release capsules) |
8,557,283 9,089,608 9,463,246 9,533,046 9,901,640 |
| Neurocrine Biosciences, Inc. v. Zydus Pharms. (USA) Inc., 25-3354 (D.N.J.) | Apr. 25, 2025 | Hon. Karen M. Williams | Ingrezza® Sprinkle (valbenazine capsules) |
8,039,627 8,357,697 10,065,952 10,844,058 10,851,103 10,851,104 10,857,137 10,857,148 10,874,648 10,906,902 10,906,903 10,912,771 10,919,892 10,940,141 10,952,997 10,993,941 11,026,931 11,026,939 11,040,029 11,311,532 |
| Neurocrine Biosciences, Inc. v. Zydus Pharms. (USA) Inc., 25-0509 (D. Del.) | Apr. 25, 2025 | Hon. Maryellen Noreika | Ingrezza® Sprinkle (valbenazine capsules) |
8,039,627 8,357,697 10,065,952 10,844,058 10,851,103 10,851,104 10,857,137 10,857,148 10,874,648 10,906,902 10,906,903 10,912,771 10,919,892 10,940,141 10,952,997 10,993,941 11,026,931 11,026,939 11,040,029 11,311,532 |
| Bausch & Lomb Inc. v. Somerset Therapeutics, LLC, 25-3395 (D.N.J.) | Apr. 28, 2025 | Hon. Robert Kirsch | Lumify® (brimonidine tartrate ophthalmic solution) |
8,293,742 9,259,425 11,596,600 11,833,245 |
| Boehringer Ingelheim Pharms. Inc. v. Biocon Ltd., 25-0523 (D. Del.) | Apr. 30, 2025 | Hon. Colm F. Connolly | Tradjenta® (linagliptin tablets) |
8,853,156 9,486,526 10,034,877 11,911,388 |
| Aurinia Pharms. Inc. v. DifGen Pharms. LLC, 25-3533 (D.N.J.) | Apr. 30, 2025 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Aurinia Pharms. Inc. v. DifGen Pharms. LLC, 25-0530 (D. Del.) | 1-May-25 | Hon. Jennifer L. Hall | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Aurinia Pharms. Inc. v. Dr. Reddy’s Labs., Inc., 25-3693 (D.N.J.) | 1-May-25 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Axsome Malta Ltd. v. Aurobindo Pharma USA, Inc., 25-3721 (D.N.J.) | 1-May-25 | Hon. Madeline Cox Arleo | Sunosi® (solriamfetol tablets) |
12,194,016 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00945 (PTAB) | 1-May-25 | N/A | Akynzeo® (netupitant / palonosetron HCl capsules) |
8,623,826 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00946 (PTAB) | 1-May-25 | N/A | Akynzeo® (netupitant / palonosetron HCl capsules) |
9,186,357 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00947 (PTAB) | 1-May-25 | N/A | Akynzeo® (netupitant / palonosetron HCl capsules) |
9,186,357 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00948 (PTAB) | 1-May-25 | N/A | Akynzeo® (netupitant / palonosetron HCl capsules) |
9,943,515 |
| Azurity Pharms., Inc. v. Helsinn Healthcare S.A., IPR2025-00949 (PTAB) | 1-May-25 | N/A | Akynzeo® (netupitant / palonosetron HCl capsules) |
10,828,297 |
| Vifor (Int’l) AG v. Orbicular Pharm. Technologies Pvt. Ltd., 25-0540 (D. Del.) | 2-May-25 | Hon. Colm F. Connolly | Injectafer® (ferric carboxymaltose injection) |
7,612,109 7,754,702 8,895,612 11,433,091 11,478,502 |
| Theravance Biopharma R&D IP, LLC v. Eugia Pharma Specialties Ltd., 25-3790 (D.N.J.) | 2-May-25 | Hon. Karen M. Williams | Yupelri® (revefenacin oral inhalation solution) |
12,285,417 |
| Aveo Pharms., Inc. v. Somerset Therapeutics, LLC, 25-0560 (D. Del.) | 7-May-25 | Hon. Maryellen Noreika | Fotivda® (tivozanib HCl capsules) |
11,504,365 |
| Azurity Pharms., Inc. v. Alkem Labs. Ltd., 25-0563 (D. Del.) | 7-May-25 | Hon. Gregory B. Williams | Zonisade® (zonisamide oral suspension) |
11,478,456 11,529,333 |
| Pfizer Inc. v. Alkem Labs. Ltd., 25-0565 (D. Del.) | 7-May-25 | Hon. Colm F. Connolly | Xeljanz® XR (tofacitinib citrate extended-release tablets) |
RE41,783 |
| Pharmacosmos A/S v. Hetero Labs Ltd., 25-3945 (D.N.J.) | 7-May-25 | Hon. Julien Xavier Neals | Cosela® (trilaciclib for injection) |
11,529,352 12,168,666 |
| Pharmacosmos A/S v. Dr. Reddy’s Labs., Inc., 25-3967 (D.N.J.) | 7-May-25 | Hon. Julien Xavier Neals | Cosela® (trilaciclib for injection) |
8,598,186 8,598,197 9,957,276 10,189,849 10,189,850 10,927,120 11,040,042 9,487,530 10,085,992 10,966,984 11,717,523 11,529,352 12,168,666 |
| Aurinia Pharms. Inc. v. Sandoz Inc., 25-3986 (D.N.J.) | 8-May-25 | Hon. Jamel K. Semper | Lupkynis® (voclosporin capsules) |
10,286,036 11,622,991 |
| Incyte Corp. v. Apotex Inc., 25-4044 (D.N.J.) | 8-May-25 | Hon. Christine P. O’Hearn | Jakafi® (ruxolitinib tablets) |
7,598,257 8,415,362 8,722,693 8,822,481 8,829,013 |
| Novartis Pharms. Corp. v. Lupin Ltd., 25-0578 (D. Del.) | 9-May-25 | Hon. John F. Murphy | Mayzent® (siponimod tablets) |
8,492,441 11,944,602 |
| United Therapeutics Corp. v. Liquidia Techs., Inc., 25-0368 (M.D.N.C.) | 9-May-25 | Hon. Thomas D. Schroeder | Yutrepia® (treprostinil inhalation powder) |
11,357,782 |
| Novartis Pharms. Corp. v. Dr. Reddy’s Labs., Ltd., 25-4282 (D.N.J.) | 15-May-25 | Hon. Renee Marie Bumb | Mayzent® (siponimod tablets) |
8,492,441 11,944,602 |
| American Regent, Inc. v. BPI Labs, LLC, 25-4439 (D.N.J.) | 16-May-25 | Hon. Brian R. Martinotti | Selenious Acid | 11,998,565 12,150,957 |
| Pfizer Inc. v. Somerset Therapeutics LLC, 25-0617 (D. Del.) | 16-May-25 | Hon. Colm F. Connolly | Xeljanz® (tofacitinib tablets) |
RE41,783 |
| AbbVie Inc. v. Hetero Labs Ltd., 25-0625 (D. Del.) | 19-May-25 | Hon. Jennifer L. Hall | Orilissa® (elagolix sodium tablets) |
12,102,637 |
| Pfizer Inc. v. Macleods Pharms. Ltd., 25-0632 (D. Del.) | 21-May-25 | Hon. Colm F. Connolly | Xeljanz® (tofacitinib tablets) |
RE41,783 |
| Bayer Pharma AG v. Aurobindo Pharma Ltd., 25-0631 (D. Del.) | 21-May-25 | Hon. Richard G. Andrews | Xarelto® (rivaroxaban tablets) |
10,828,310 |
| Aveo Pharms., Inc. v. Hetero USA Inc., 25-0639 (D. Del.) | 23-May-25 | Hon. Maryellen Noreika | Fotivda® (tivozanib HCl capsules) |
11,504,365 |
| Novartis Pharms. Corp. v. Zenara Pharma Private Ltd., 25-0644 (D. Del.) | 23-May-25 | Hon. Gregory B. Williams | Promacta® (eltrombopag olamine tablets) |
8,828,430 |
| Incyte Corp. v. Padagis Israel Pharms. Ltd., 25-5380 (D.N.J.) | 23-May-25 | Hon. Madeline Cox Arleo | Opzelura® (ruxolitinib cream) |
12,226,419 |
| Otsuka America Pharm., Inc. v. Hetero Labs Ltd., 25-0647 (D. Del.) | 27-May-25 | Hon. Gregory B. Williams | Nuedexta® (dextromethorphan hydrobromide / quinidine sulfate capsules) |
7,659,282 |
| Fennec Pharms. Inc. v. Cipla Ltd., 25-5709 (D.N.J.) | 27-May-25 | Hon. Jamel K. Semper | Pedmark® (sodium thiosulfate injection) |
12,311,026 |
| Boehringer Ingelheim Pharms. Inc. v. Granules India Ltd., 25-0663 (D. Del.) | 29-May-25 | Hon. Colm F. Connolly | Jardiance® (empagliflozin tablets) |
9,949,998 10,258,637 11,090,323 11,833,166 |
| Celgene Corp. v. USV Private Ltd., 25-6320 (D.N.J) | 30-May-25 | Hon. Esther Salas | Pomalyst® (pomalidomide capsules) |
8,828,427 9,993,467 10,555,939 |
| Incyte Corp. v. Taro Pharms. Inc., 25-7243 (D.N.J.) | 4-Jun-25 | Hon. Madeline Cox Arleo | Opzelura® (ruxolitinib cream) |
12,226,419 |
| Bayer Pharma AG v. Apotex Inc., 25-0694 (D. Del.) | 5-Jun-25 | Hon. Richard G. Andrews | Xarelto® (rivaroxaban tablets) |
10,828,310 |
| American Regent, Inc. v. BPI Labs, LLC, 25-1470 (M.D. Fla.) | 6-Jun-25 | Hon. William F. Jung | Selenious Acid | 11,998,565 12,150,957 |
| Bayer Pharma AG v. Macleods Pharms. Ltd., 25-0719 (D. Del.) | 9-Jun-25 | Hon. Richard G. Andrews | Xarelto® (rivaroxaban tablets) |
10,828,310 |
| Salix Pharms., Inc. v. Alkem Labs. Ltd., 25-9344 (D.N.J.) | 10-Jun-25 | Hon. John F. Murphy | Xifaxan® (rifaximin tablets) |
11,779,571 11,564,912 8,193,196 |
| United Therapeutics Corp. v. Actelion Pharms., Ltd., IPR2025-01139 (PTAB) | 10-Jun-25 | N/A | Opsumit® (macitentan tablets) Opsynvi® (macitentan / tadalafil tablets) |
8,268,847 |
| Aveo Pharms., Inc. v. Glenmark Pharms. Ltd., 25-0735 (D. Del.) | 13-Jun-25 | Hon. Maryellen Noreika | Fotivda® (tivozanib HCl capsules) |
11,504,365 7,166,722 |
| Braintree Labs., Inc. v. Appco Pharma LLC, 25-10876 (D.N.J.) | 13-Jun-25 | Hon. Christine P. O’Hearn | Sutab® (sodium sulfate / magnesium sulfate / potassium chloride osmotic laxative tablets) |
10,143,656 11,033,498 11,382,864 11,638,697 |
| Pfizer Inc. v. Orient Pharma Co., Ltd., 25-0743 (D. Del.) | 16-Jun-25 | Hon. Gregory B. Williams | Xeljanz® XR (tofacitinib citrate extended-release tablets) |
9,937,181 10,639,309 11,253,523 |
| Bayer Pharma AG v. Alembic Pharms. Ltd., 25-0753 (D. Del.) | 18-Jun-25 | Hon. Richard G. Andrews | Xarelto® (rivaroxaban tablets) |
10,828,310 |
| Bayer Pharma AG v. Hetero Labs Ltd., 25-0754 (D. Del.) | 18-Jun-25 | Hon. Richard G. Andrews | Xarelto® (rivaroxaban tablets) |
10,828,310 |
| Aragon Pharms., Inc. v. Hetero Labs Ltd. Unit V., 25-11924 (D.N.J.) | 18-Jun-25 | Hon. Stanley R. Chesler | Erleada® (apalutamidetablets) |
8,445,507 8,802,689 9,388,159 9,987,261 9,481,663 9,884,054 RE49,353 10,849,888 10,702,508 11,963,952 |
| American Regent, Inc. v. Endo Operations Ltd., 25-11945 (D.N.J.) | 18-Jun-25 | Hon. Brian R. Martinotti | Tralement® (trace elements zinc sulfate / cupric sulfate / manganese sulfate / selenious acid injection) |
11,786,548 11,975,022 11,998,565 12,150,956 12,150,957 |
| Indivior Inc. v. Lupin Inc., 25-0757 (D. Del.) | 20-Jun-25 | Hon. Jennifer L. Hall | Opvee® (nalmefene Nasal spray) |
11,458,091 12,290,596 |
| Amneal Pharms. LLC v. Sandoz Inc., 25-11981 (D.N.J.) | 20-Jun-25 | Hon. Georgette Castner | Crexont® (carbidopa / levodopa extended-release capsules) |
12,201,596 12,263,148 12,263,149 12,274,793 |
| Pfizer Inc. v. Apotex Inc., 25-0765 (D. Del.) | 20-Jun-25 | Hon. Colm F. Connolly | Ibrance® (palbociclib tablets) |
RE47,739 |
| Novo Nordisk Inc. v. Sun Pharm. Indus. Ltd., 25-0767 (D. Del.) | 20-Jun-25 | Hon. Colm F. Connolly | Wegovy® (semaglutide injection) |
12,214,017 |
| Pfizer Inc. v. Apotex Inc., 25-0775 (D. Del.) | 23-Jun-25 | Hon. Colm F. Connolly | Xeljanz® XR (tofacitinib extended-release tablets) |
RE41,783 |
| Braintree Labs., Inc. v. Alkem Labs. Ltd., 25-12118 (D.N.J.) | 25-Jun-25 | Hon. Christine P. O’Hearn | Sutab® (sodium sulfate / magnesium sulfate / potassium chloride osmotic laxative tablets) |
10,143,656 11,033,498 11,382,864 11,638,697 |
| American Regent, Inc. v. Amneal Pharms. of NY, LLC, 25-12169 (D.N.J.) | 26-Jun-25 | Hon. Brian R. Martinotti | Multrys® (trace elements injection) |
11,786,548 11,975,022 11,998,565 12,150,956 |
| Supernus Pharms., Inc. v. Appco Pharma LLC, 25-12183 (D.N.J.) | 26-Jun-25 | Hon. Michael E. Farbiarz | Qelbree® (viloxazine extended-release capsules) |
9,358,204 9,603,853 9,662,338 11,324,753 11,458,143 12,121,523 |
| Supernus Pharms., Inc. v. Apotex Inc., 25-12184 (D.N.J.) | 26-Jun-25 | Hon. Michael E. Farbiarz | Qelbree® (viloxazine extended-release capsules) |
9,358,204 9,603,853 9,662,338 11,324,753 11,458,143 12,121,523 |
| Supernus Pharms., Inc. v. Aurobindo Pharma Ltd., 25-12186 (D.N.J.) | 26-Jun-25 | Hon. Michael E. Farbiarz | Qelbree® (viloxazine extended-release capsules) |
9,358,204 9,603,853 9,662,338 11,324,753 11,458,143 12,121,523 |
| Supernus Pharms., Inc. v. Zydus Lifesciences Global FZE, 25-12188 (D.N.J.) | 26-Jun-25 | Hon. Michael E. Farbiarz | Qelbree® (viloxazine extended-release capsules) |
9,358,204 9,603,853 9,662,338 |
| Novartis Pharms. Corp. v. Eugia Pharma Specialities Ltd., 25-800 (D. Del.) | 27-Jun-25 | Hon. Gregory B. Williams | Tasigna® (nilotinib HCl capsules) |
8,163,904 8,293,756 8,389,537 8,415,363 8,501,760 9,061,029 |
| Eli Lilly & Co. v. Qilu Pharm. Co., Ltd., 25-12347 (D.N.J.) | 30-Jun-25 | Hon. Evelyn Padin | Reyvow® (lasmiditan tablets) |
12,257,246 |
